UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Role of Tissue Factor in Cancer-Related Hypercoagulability, Tumor Growth, Angiogenesis and Metastasis and Future Therapeutic Strategies

Critical reviews in oncogenesis, 2017, Vol.22 (3-4), p.219-248

2017

Volltextzugriff (PDF)

Risque thromboembolique en oncologie : réalités, actualités et perspectives

Bulletin du cancer, 2016-09, Vol.103 (9), p.764-775

2016

Volltextzugriff (PDF)

Public Awareness on Cancer-Associated Thrombosis among the Greek Population: First Findings from the ROADMAP-CAT Awareness Study

TH open : companion journal to thrombosis and haemostasis, 2022-04, Vol.6 (2), p.e89-e95

2022

Volltextzugriff (PDF)

Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI

TH open : companion journal to thrombosis and haemostasis, 2019-07, Vol.3 (3), p.e309-e315

2019

Volltextzugriff (PDF)

Khorana Score: Νew Predictor of Early Mortality in Patients With Lung Adenocarcinoma

Clinical and applied thrombosis/hemostasis, 2018-11, Vol.24 (8), p.1347-1351

2018

Volltextzugriff (PDF)

Modelization of Blood-Borne Hypercoagulability in Myeloma: A Tissue-Factor-Bearing Microparticle-Driven Process

TH open : companion journal to thrombosis and haemostasis, 2019-10, Vol.3 (4), p.e340-e347

2019

Volltextzugriff (PDF)

Erratum: Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI

TH open : companion journal to thrombosis and haemostasis, 2019-10, Vol.3 (4), p.e348-e349

2019

Volltextzugriff (PDF)

The role of platelets and recombinant factor VIIa on thrombin generation, platelet activation and clot formation

Thrombosis and haemostasis, 2004-05, Vol.91 (5), p.977-985

2004

Volltextzugriff (PDF)

Analysis of Inter-Observer Agreement of Adjudication of Colors of Pad Colors of Doac Dipstick to Determine Presence or Absence of Direct Oral Anticoagulants in Outpatients' Urine Samples

Blood, 2021-11, Vol.138 (Supplement 1), p.3213-3213

2021

Volltextzugriff (PDF)

The Procoagulant Phospholipid Dependent Clotting Time and the Initiation Phase of Thrombin Generation Test Are Mandatory for the Evaluation of the Risk for Severe Early Onset Preeclampsia

Blood, 2023-11, Vol.142 (Supplement 1), p.5406-5406

2023

Volltextzugriff (PDF)

Amplified Thrombo-Inflammatory Biomarkers in Pulmonary Embolism with Augmented Responses in Von-Willebrand Factor, Microparticles and Interleukin-6 in Patients with Cancer

Blood, 2022-11, Vol.140 (Supplement 1), p.11211-11213

2022

Volltextzugriff (PDF)

Leukemia Inhibitory Factor, Tissue Factor, Thrombomodulin, P-Selectine, D-Dimer, Thrombin Generation and Procoagulant Phospholipid Dependent Clotting Time Are Predictive for in Vitro Fertilization Outcome. the Prospective Roadmap-IVF Study

Blood, 2023-11, Vol.142 (Supplement 1), p.5413-5413

2023

Volltextzugriff (PDF)

Elevated Thrombin Generation Biomarkers and Their Relevance with Decreased Thrombin Generation Potential in Patients with Pulmonary Embolism

Blood, 2022-11, Vol.140 (Supplement 1), p.11214-11215

2022

Volltextzugriff (PDF)

Prothrombotic Profile in Patients with Active Multiple Myeloma and the Impact of Immunomodulators: The Roadmap-MM Study

Blood, 2023-11, Vol.142 (Supplement 1), p.1203-1203

2023

Volltextzugriff (PDF)

Evaluation of Clinical Risk Factors and Thrombosis-Related Biomarkers in Newly Diagnosed Patients with Multiple Myeloma at Risk for Cancer-Associated Thrombosis. the Observational Roadmat-CAT-MM Study

Blood, 2023-11, Vol.142 (Supplement 1), p.5404-5404

2023

Volltextzugriff (PDF)

Derivation and Validation of a Predictive Score for Disease Worsening Inpatients with COVID-19

Blood, 2020-11, Vol.136 (Supplement 1), p.26-27

2020

Volltextzugriff (PDF)

Stratification of Vascular Profile in Multiple Myeloma Patients Using Thrombin Generation Test

Blood, 2020-11, Vol.136 (Supplement 1), p.4-4

2020

Volltextzugriff (PDF)

Decreased Thrombin Generation Potential in Lymphoma Patients is associated with Increased D‐dimer, CRP, vWF and TNF‐α. Interrelationship between Thrombogenesis and Inflammation

The FASEB journal, 2020-04, Vol.34 (S1), p.1-1

2020

Volltextzugriff (PDF)

Differential Augmentation of Thrombin Generation by Andexanet Alfa in Lymphoma Patients

The FASEB journal, 2020-04, Vol.34 (S1), p.1-1

2020

Volltextzugriff (PDF)

Cancer Cells and Platelets Have a Synergistic Role on the Acceleration of Clot Formation and Fibrin Polymerization. a Thromboelastometric Study

Blood, 2022-11, Vol.140 (Supplement 1), p.11284-11285

2022

Volltextzugriff (PDF)

Decreased Thrombin Generation Potential in Lymphoma Patients Is Associated with Increased D-Dimer, CRP, Vwf and TNF-α. Interrelationship between Thrombogenesis and Inflammation

Blood, 2019-11, Vol.134 (Supplement_1), p.5239-5239

2019

Volltextzugriff (PDF)

The Compass-COVID19-ICU Study: Identification of Factors to Predict the Risk of Intubation and Mortality in Patients with Severe COVID-19

Blood, 2021-11, Vol.138 (Supplement 1), p.2121-2121

2021

Volltextzugriff (PDF)

Bacterial coinfection in critically ill COVID-19 patients with severe pneumonia

Infection, 2021-06, Vol.49 (3), p.559-562

2021

Volltextzugriff (PDF)

Risque thromboembolique en oncologie : réalités, actualités et perspectives

Bulletin du cancer, 2016-09, Vol.103 (9), p.764-775

2016

Volltextzugriff (PDF)

Hypercoagulability Biomarkers in a New Score Linked to Treatment Resistance for Multiple Myeloma Patients. the Roadmap-MM Study

Blood, 2019-11, Vol.134 (Supplement_1), p.1913-1913

2019

Volltextzugriff (PDF)

1 – 25 von 73

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(69)
Mit Volltextzugriff
(62)

Publikationsform

Sprache

Englisch
(66)
Französisch
(8)

Erscheinungsjahr

n.n

Thema

Life Sciences
(9)
Humans
(6)
Cancer
(5)
Thrombin Generation
(5)
Tissue Factor
(4)
Biological And Medical Sciences
(3)
Deep Vein Thrombosis
(3)
Hypercoagulability
(3)
Medical Sciences
(3)
Original
(3)
Pulmonary Embolism
(3)
Venous Thromboembolism
(3)
Aged
(2)
Female
(2)
Fundamental And Applied Biological Sciences. Psychology
(2)
Hematology, Oncology And Palliative Medicine
(2)
Low Molecular Weight Heparin
(2)
Microparticles
(2)
Middle Aged
(2)
Original Article
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Role of Tissue Factor in Cancer-Related Hypercoagulability, Tumor Growth, Angiogenesis and Metastasis and Future Therapeutic Strategies

Risque thromboembolique en oncologie : réalités, actualités et perspectives

Public Awareness on Cancer-Associated Thrombosis among the Greek Population: First Findings from the ROADMAP-CAT Awareness Study

Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI

Khorana Score: Νew Predictor of Early Mortality in Patients With Lung Adenocarcinoma

Modelization of Blood-Borne Hypercoagulability in Myeloma: A Tissue-Factor-Bearing Microparticle-Driven Process

Erratum: Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI

The role of platelets and recombinant factor VIIa on thrombin generation, platelet activation and clot formation

Analysis of Inter-Observer Agreement of Adjudication of Colors of Pad Colors of Doac Dipstick to Determine Presence or Absence of Direct Oral Anticoagulants in Outpatients' Urine Samples

The Procoagulant Phospholipid Dependent Clotting Time and the Initiation Phase of Thrombin Generation Test Are Mandatory for the Evaluation of the Risk for Severe Early Onset Preeclampsia

Amplified Thrombo-Inflammatory Biomarkers in Pulmonary Embolism with Augmented Responses in Von-Willebrand Factor, Microparticles and Interleukin-6 in Patients with Cancer

Leukemia Inhibitory Factor, Tissue Factor, Thrombomodulin, P-Selectine, D-Dimer, Thrombin Generation and Procoagulant Phospholipid Dependent Clotting Time Are Predictive for in Vitro Fertilization Outcome. the Prospective Roadmap-IVF Study

Elevated Thrombin Generation Biomarkers and Their Relevance with Decreased Thrombin Generation Potential in Patients with Pulmonary Embolism

Prothrombotic Profile in Patients with Active Multiple Myeloma and the Impact of Immunomodulators: The Roadmap-MM Study

Evaluation of Clinical Risk Factors and Thrombosis-Related Biomarkers in Newly Diagnosed Patients with Multiple Myeloma at Risk for Cancer-Associated Thrombosis. the Observational Roadmat-CAT-MM Study

Derivation and Validation of a Predictive Score for Disease Worsening Inpatients with COVID-19

Stratification of Vascular Profile in Multiple Myeloma Patients Using Thrombin Generation Test

Decreased Thrombin Generation Potential in Lymphoma Patients is associated with Increased D‐dimer, CRP, vWF and TNF‐α. Interrelationship between Thrombogenesis and Inflammation

Differential Augmentation of Thrombin Generation by Andexanet Alfa in Lymphoma Patients

Cancer Cells and Platelets Have a Synergistic Role on the Acceleration of Clot Formation and Fibrin Polymerization. a Thromboelastometric Study

Decreased Thrombin Generation Potential in Lymphoma Patients Is Associated with Increased D-Dimer, CRP, Vwf and TNF-α. Interrelationship between Thrombogenesis and Inflammation

The Compass-COVID19-ICU Study: Identification of Factors to Predict the Risk of Intubation and Mortality in Patients with Severe COVID-19

Bacterial coinfection in critically ill COVID-19 patients with severe pneumonia

Risque thromboembolique en oncologie : réalités, actualités et perspectives

Hypercoagulability Biomarkers in a New Score Linked to Treatment Resistance for Multiple Myeloma Patients. the Roadmap-MM Study

Aktive Filter

Suchergebnisse filtern